AnaConDa® Reflection Filter: Bench and Patient Evaluation of Safety and Volatile Anesthetic Conservation

BACKGROUND:The AnaConDa® filter permits administration of volatile anesthetic without the use of an anesthesia machine. It is intended for use in the intensive care unit. METHODS:We studied the AnaConDa® reflection filter on the bench and in anesthetized patients. The bench analysis used a test lung, a gas analyzer, an intensive care ventilator, the AnaConDa® filter, and a syringe pump. We studied a range of tidal volume, respiratory rate, and positive end-expiratory pressure values. We simulated errors during syringe refilling and patient transportation. In 15 anesthetized patients, we used the AnaConDa® with constant ventilation variables, a constant sevoflurane infusion rate (4–5 mL/h), and two consecutive fresh gas flow levels. RESULTS:In the bench study, the expired volatile anesthetic fraction decreased linearly with respiratory frequency at constant minute ventilation, and decreased markedly in a hyperbolical manner when tidal volume increased at a constant respiratory rate. Changing the positive end-expiratory pressure level and inspiration/expiration ratio did not modify the AnaConDa®’s performance. Several safety failures were observed: refilling caused a transient change in AnaConDa® output because of a pumping effect, and a standard Luer lock made it possible to connect the halogenate syringe on an IV infusion line. In anesthetized patients, reducing fresh gas flow from 8 to 1 L/min led to a median 40% increase in the expired volatile anesthetic fraction. CONCLUSIONS:This study shows that the device is generally reliable, but that there are several conditions under which it might deliver more anesthetic than intended.

[1]  H. Hayashi,et al.  Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. , 2008, Artificial organs.

[2]  M. Olivei,et al.  The Anesthetic Conserving Device Compared with Conventional Circle System Used Under Different Flow Conditions for Inhaled Anesthesia , 2003, Anesthesia and analgesia.

[3]  L. Wiklund,et al.  A new device to reduce the consumption of a halogenated anaesthetic agent. , 2002, Anaesthesia.

[4]  M. Enlund,et al.  A new device to reduce the consumption of a halogenated anaesthetic agent* , 2001 .

[5]  P. Reinstrup,et al.  Charcoal as an airway isoflurane reflection filter. , 1998, European journal of anaesthesiology.

[6]  J. Eddleston,et al.  Inorganic fluoride concentration after long-term sedation with isoflurane , 1996, Intensive Care Medicine.

[7]  E. Bennett,et al.  Isoflurane and propofol for long‐term sedation in the intensive care unit , 1992, Anaesthesia.

[8]  S. Willatts,et al.  Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal function. , 1991, Anesthesia and analgesia.

[9]  S. Willatts,et al.  Isoflurane compared with midazolam for sedation in the intensive care unit. , 1989, BMJ.

[10]  R. Thomasson,et al.  A reflection filter for isoflurane and other anaesthetic vapours. , 1989, European journal of anaesthesiology.

[11]  D. Feigin Misconceptions regarding the pathogenicity of silicas and silicates , 1989, Journal of thoracic imaging.

[12]  N. Soni,et al.  Isoflurane in the treatment of asthma , 1988, Anaesthesia.

[13]  M. Bierman,et al.  Prolonged isoflurane anesthesia in status asthmaticus. , 1986, Critical care medicine.

[14]  S. Willatts,et al.  Plasma Inorganic Fluoride Concentrations During and After Prolonged (>24 h) Isoflurane Sedation: Effect on Renal Function , 2006 .

[15]  S. Coles,et al.  Prevention of atmospheric contamination during isoflurane sedation. , 1994, Clinical intensive care : international journal of critical & coronary care medicine.

[16]  L. Simonato,et al.  Relation of environmental exposure to erionite fibres to risk of respiratory cancer. , 1989, IARC scientific publications.